It’s been two years since the deadline for CBD companies to apply for the Food Standards Agency (FSA) novel foods authorisation, yet none have been authorised and few have been validated, a process that some experts say is causing the CBD market to stagnate.
“It’s not a system that’s working,” said Sarah Ellson, a partner and co-head of the regulatory group at Fieldfisher. “We have clients in other sort of food and nutrition spaces, and they’re frustrated with waits of months for products to get approved, but to have to wait years… it’s just going to kill innovation.”